Follow
Pedro M M Mesquita
Pedro M M Mesquita
Associate Medical Director at Uniphar
Verified email at uniphar.ie
Title
Cited by
Cited by
Year
Griffithsin protects mice from genital herpes by preventing cell-to-cell spread
B Nixon, M Stefanidou, PMM Mesquita, E Fakioglu, T Segarra, L Rohan, ...
Journal of virology 87 (11), 6257-6269, 2013
1382013
Disruption of tight junctions by cellulose sulfate facilitates HIV infection: model of microbicide safety
PMM Mesquita, N Cheshenko, SS Wilson, M Mhatre, E Guzman, ...
The Journal of infectious diseases 200 (4), 599-608, 2009
1382009
A compartmental pharmacokinetic evaluation of long‐acting rilpivirine in HIV‐negative volunteers for pre‐exposure prophylaxis
AGA Jackson, LJ Else, PMM Mesquita, D Egan, DJ Back, Z Karolia, ...
Clinical Pharmacology & Therapeutics 96 (3), 314-323, 2014
1192014
Intravaginal ring eluting tenofovir disoproxil fumarate completely protects macaques from multiple vaginal simian-HIV challenges
JM Smith, R Rastogi, RS Teller, P Srinivasan, PMM Mesquita, U Nagaraja, ...
Proceedings of the National Academy of Sciences 110 (40), 16145-16150, 2013
1172013
Bacterial vaginosis and subclinical markers of genital tract inflammation and mucosal immunity
AR Thurman, T Kimble, B Herold, PMM Mesquita, RN Fichorova, ...
AIDS research and human retroviruses 31 (11), 1139-1152, 2015
1062015
Herpes simplex virus downregulates secretory leukocyte protease inhibitor: a novel immune evasion mechanism
E Fakioglu, SS Wilson, PMM Mesquita, E Hazrati, N Cheshenko, JA Blaho, ...
Journal of virology 82 (19), 9337-9344, 2008
1042008
Intravaginal ring delivery of tenofovir disoproxil fumarate for prevention of HIV and herpes simplex virus infection
PMM Mesquita, R Rastogi, TJ Segarra, RS Teller, NM Torres, AM Huber, ...
Journal of antimicrobial chemotherapy 67 (7), 1730-1738, 2012
972012
Candidate polyanion microbicides inhibit HIV-1 infection and dissemination pathways in human cervical explants
PS Fletcher, GS Wallace, PMM Mesquita, RJ Shattock
Retrovirology 3, 1-12, 2006
942006
A randomized trial to assess anti-HIV activity in female genital tract secretions and soluble mucosal immunity following application of 1% tenofovir gel
MJ Keller, RP Madan, NM Torres, MJ Fazzari, S Cho, S Kalyoussef, ...
PloS one 6 (1), e16475, 2011
922011
Postcoital bioavailability and antiviral activity of 0.5% PRO 2000 gel: implications for future microbicide clinical trials
MJ Keller, PMM Mesquita, NM Torres, S Cho, G Shust, RP Madan, ...
PLoS One 5 (1), e8781, 2010
772010
Susceptibility to genital herpes as a biomarker predictive of increased HIV risk: expansion of a murine model of microbicide safety
SS Wilson, N Cheshenko, E Fakioglu, PMM Mesquita, MJ Keller, ...
Antiviral therapy 14 (8), 1113-1124, 2009
482009
Female genital tract secretions and semen impact the development of microbicides for the prevention of HIV and other sexually transmitted infections
BC Herold, PM Mesquita, RP Madan, MJ Keller
American journal of reproductive immunology 65 (3), 325-333, 2011
452011
Molecular umbrellas: a novel class of candidate topical microbicides to prevent human immunodeficiency virus and herpes simplex virus infections
RP Madan, PMM Mesquita, N Cheshenko, B Jing, V Shende, E Guzman, ...
Journal of virology 81 (14), 7636-7646, 2007
442007
A phase 1 randomized placebo-controlled safety and pharmacokinetic trial of a tenofovir disoproxil fumarate vaginal ring
MJ Keller, PM Mesquita, MA Marzinke, R Teller, L Espinoza, JM Atrio, ...
Aids 30 (5), 743-751, 2016
432016
Differential mechanisms of tenofovir and tenofovir disoproxil fumarate cellular transport and implications for topical preexposure prophylaxis
E Taneva, K Crooker, SH Park, JT Su, A Ott, N Cheshenko, I Szleifer, ...
Antimicrobial agents and chemotherapy 60 (3), 1667-1675, 2016
422016
Bridging the gap between preclinical and clinical microbicide trials: blind evaluation of candidate gels in murine models of efficacy and safety
TJ Segarra, E Fakioglu, N Cheshenko, SS Wilson, PMM Mesquita, ...
PloS one 6 (11), e27675, 2011
382011
Vaginal microbiome modulates topical antiretroviral drug pharmacokinetics
E Taneva, S Sinclair, PMM Mesquita, B Weinrick, SA Cameron, ...
JCI insight 3 (13), 2018
362018
Comparison of follicular and luteal phase mucosal markers of HIV susceptibility in healthy women
AR Thurman, N Chandra, N Yousefieh, I Zalenskaya, T Kimble, S Asin, ...
AIDS research and human retroviruses 32 (6), 547-560, 2016
362016
Candidate microbicide PPCM blocks human immunodeficiency virus type 1 infection in cell and tissue cultures and prevents genital herpes in a murine model
PMM Mesquita, SS Wilson, P Manlow, L Fischetti, MJ Keller, BC Herold, ...
Journal of Virology 82 (13), 6576-6584, 2008
362008
Comparison of mucosal markers of human immunodeficiency virus susceptibility in healthy premenopausal versus postmenopausal women
AR Thurman, N Yousefieh, N Chandra, T Kimble, S Asin, C Rollenhagen, ...
AIDS research and human retroviruses 33 (8), 807-819, 2017
322017
The system can't perform the operation now. Try again later.
Articles 1–20